CRISPR Therapeutics AG

Direct answer

CRISPR Therapeutics AG is publicly traded on NASDAQ under the ticker CRSP.

CRISPR Therapeutics AG (CRSP) is a biotechnology firm dedicated to pioneering gene-based medicines for severe diseases. The company achieves this through its exclusive Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) technology, which enables precise and targeted alterations to an organism's genetic code. Its extensive pipeline includes therapeutic candidates...

Can you invest in CRISPR Therapeutics AG?

Yes. CRISPR Therapeutics AG is publicly traded on NASDAQ under the ticker CRSP.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for CRISPR Therapeutics AG

Detailed equity research is provided by MarketSnap.